Post-treatment heterogeneity of cardiometabolic risk in patients with acromegaly: The impact of GH and IGF-1
- 9 June 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Endocrine Research
- Vol. 47 (1), 1-7
- https://doi.org/10.1080/07435800.2021.1931298
Abstract
Metabolic abnormalities are frequently seen in patients with acromegaly. However, it is not clear to what extent growth hormone/insulin-like growth factor-1 (GH/IGF-1) contributes to the developmen...Keywords
Funding Information
- funded
This publication has 23 references indexed in Scilit:
- Cardiovascular involvement in patients affected by acromegaly: An appraisalInternational Journal of Cardiology, 2013
- A consensus on the diagnosis and treatment of acromegaly complicationsPituitary, 2012
- Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative studyPituitary, 2011
- Hypertension-related factors in patients with active and inactive acromegalyArchives of Endocrinology and Metabolism, 2011
- Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly RegistryActa Endocrinologica, 2011
- Clinical, quality of life, and economic value of acromegaly disease controlPituitary, 2011
- Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic β-cell function is preservedActa Endocrinologica, 2011
- Biological effects of growth hormone on carbohydrate and lipid metabolismGrowth Hormone & IGF Research, 2010
- Divergence between Growth Hormone and Insulin-Like Growth Factor-I Concentrations in the Follow-Up of AcromegalyJournal of Clinical Endocrinology & Metabolism, 2008
- Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and ManagementEndocrine Reviews, 2004